Redesigned Fat-Based Drug Carriers Extend Pain Relief From Hours to Weeks

Researchers at Boston Children's Hospital engineered microscopic lipid carriers to release anesthetic medication far more slowly than conventional formulations. Testing with pufferfish toxin in rats demonstrated sustained nerve blocks lasting two to three weeks compared to four to eight hours for commercial versions. The approach suggests a promising path toward reducing post-surgical pain management needs through extended-duration local anesthetics.

Liposomes have long served as delivery vessels in medicine, with scientists traditionally assuming that looser molecular packing would accelerate drug release. Researchers at Boston Children's Hospital discovered this assumption breaks down for water-soluble medications, which behave counterintuitively in fluid lipid structures. By incorporating multiple double bonds into lipid molecules, they created membranes that form layered, onion-like compartments rather than simple spheres, dramatically slowing medication escape while maintaining therapeutic levels.

The team selected tetrodotoxin—a potent neurotoxin from marine animals—as their test compound because of its powerful anesthetic properties. Animal studies showed the redesigned carriers extended numbness to two or three weeks while preventing toxic buildup, suggesting the body could safely metabolize the slowly released drug. This principle may apply broadly to other water-soluble medications beyond pain relief.